Literature DB >> 328385

Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses.

J E Balow, J E Parrillo, A S Fauci.   

Abstract

The direct immunosuppressive effects of cyclophosphamide were examined by incubating normal guinea-pig mononuclear cells with activated cyclophosphamide prepared from the serum of separate animals which were treated with cyclophosphamide in vivo. Treated cells were subsequently assayed in a panel of tests of cell-mediated immunity either immediately or following recovery during variable periods of incubation. It was found that cyclophosphamide (1) induces changes in lymphocyte functions which are not due simply to cell death; (2) is markedly antiproliferative in mitogen-induced blastogenesis; (3) depresses migration inhibitory factor production only after a delay of several hours and (4) depresses certain cytotoxicity reactions immediately following treatment, such responses are subsequently normalized when the cells are allowed to recover in culture.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328385      PMCID: PMC1445453     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  A reappraisal of the effector cells mediating mitogen induced cellular cytotoxicity.

Authors:  A V Muchmore; D L Nelson; H Kirchner; R M Blaese
Journal:  Cell Immunol       Date:  1975-09       Impact factor: 4.868

2.  Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate.

Authors:  E R Hurd
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

Review 3.  Immunosuppressive therapy. 1.

Authors:  M D Skinner; R S Schwartz
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

4.  Selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; L W Poulter
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

5.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

6.  Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood.

Authors:  H R MacDonald; G D Bonnard; B Sordat; S A Zawodnik
Journal:  Scand J Immunol       Date:  1975-09       Impact factor: 3.487

Review 7.  Cyclophosphamide: use in practice.

Authors:  M E Gershwin; E J Goetzl; A D Steinberg
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

8.  Requirement for T cells in the production of migration inhibitory factor.

Authors:  B R Bloom; E Shevach
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  The production of migration inhibition factor by B and T cells of the guinea pig.

Authors:  T Yoshida; H Sonozaki; S Cohen
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

Review 10.  Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens.

Authors:  M Greaves; G Janossy; M Doenhoff
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  4 in total

1.  Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.

Authors:  S A Bishop; T J Hill
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.

Authors:  F Bistoni; M Baccarini; E Blasi; P Marconi; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

3.  Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.

Authors:  D H Bovbjerg; R Ader; N Cohen
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

4.  Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement.

Authors:  Tatsuyoshi Ikeue; Hiroshi Yoshida; Eiichiro Tanaka; Issei Ohi; Susumu Noguchi; Akari Fukao; Satoshi Terashita; Sadao Horikawa; Takakazu Sugita
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.